Noah Doyle, Director at RITTER PHARMACEUTICALS INC (RTTR), bought 800,000 shares at $5.00 ($4.0M) on 2015-06-24, disclosed to the SEC on 2015-06-25.
Open-market purchase of $4.0M RTTR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.